Breaking News Today Regarding Johns Hopkins Hospital Doctors Using This Product. Up over 55% Since we Initiated Coverage Yesterday. Vuzix (NASDAQ: VUZI) Augmented Reality Provides Zoom for Healthcare.

Breaking News Today Regarding Johns Hopkins Hospital Doctors Using This Product. Up over 55% Since we Initiated Coverage Yesterday. Vuzix (NASDAQ: VUZI) Augmented Reality Provides Zoom for Healthcare.

Breaking News

Usage of Vuzix M400 Smart Glasses to Remotely Monitor COVID-19 Patients and Collaborate with Medical Staff Continues to Expand

Vuzix glasses are now being used by doctors in the Johns Hopkins Hospital ICU for training and conducting remote virtual patient rounds in response to COVID-19

ROCHESTER, N.Y., May 8, 2020 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that another leading hospital’s team of doctors is successfully using the Vuzix M400 Smart Glasses to facilitate patient care.

Full News Release-

Vuzix Tele-Medicine and Their Role in the COVID 19 Battle

VUZIX issued a press release yesteray May 7th, 2020.

Zoom for Healthcare Now Supported on Vuzix Smart Glasses for HIPAA-Compliant Telemedicine Videoconferencing

Good day everyone,

We are continuing our coverage of Vuzix Corporation (NASDAQ: VUZI), a company that designs, manufactures, markets and sells augmented reality (AR) wearable display and computing devices.

Opening price at the time of our report $1.90/share
Current price $2.25 per share
High of the day (HOD) $2.78 per share

VUZI shares have seen nice gains today (high of $2.78 +50%) in heavy trade volumes, as investors react to the news of support from ZOOM in the use of Vuzix smartglasses in the treatment of COVID 19 cases. It has been a good day for our members.

Vuzix just announced support of Zoom Healthcare, a HIPAA/PIPEDA-compliant conferencing application, for Vuzix M-Series and Vuzix Blade® Smart Glasses. Vuzix has received numerous requests from hospitals and healthcare organizations interested in leveraging Zoom for Healthcare in their day-to-day business operations with smart glasses.

The Zoom connector application from Vuzix provides Zoom for Healthcare customers with the ability to connect to the service through an interface developed specifically for Vuzix smart glasses that allows them to login, connect and share point-of-view, fed real-time from the camera of Vuzix smart glasses.

The Vuzix connector app is not only optimized for one-to-one support calls but also one-to-many, which allows remote medical professionals to share what they are seeing with all the users that have joined the meeting simultaneously.

Think of the implications. A Covid 19 patient could be seen by one healthcare professional and the encounter could be viewed by the facility’s complete staff without the risk of infection. That is the obvious benefit.

Beyond reducing infection levels to healthcare professionals, this new dynamic could allow the scientists in the biopharma sector, working on a treatment or vaccine for Covid 19, to view patients in clinical trials in real time.

This support from Zoom Healthcare may act as a catalyst for VUZI shares as well as creating a new potential standard for Covid 19 patient care.

Vuzix smartglasses are currently being used in Thailand specifically in the care of COVID-19 patients. Thailand-based Tely360, a software integration partner of Vuzix, presented their solution to Chakri Naruebodindra Medical Institute at the Faculty of Medicine Ramathibodi Hospital, Mahidol University, one of the main sites in Thailand used for the quarantine of COVID-19 patients. Tely360’s Ambulance 3rd Eye module, used with the Vuzix Blade, aids in the communication between healthcare personnel working in a negative pressure room and physicians outside the room.

Vuzix has won Consumer Electronics Show awards for innovation for the years 2005 to 2020 and several wireless technology innovation awards, among others.

Covid 19 has been with us for about 10 weeks now and has been devastating as the world healthcare system was unprepared for it. As the number of new cases is going down in certain areas, the world is relaxing social distancing and other preventative restrictions. If we believe the scientists, the potential for a second, stronger wave of Covid 19 may come in the fall. Our ability to mitigate the impact of that scenario will depend on the treatments and technologies we develop in the interim. We believe VUZI could play a positive role in that endeavor.

Sizable Short Interest
VUZI has a significant level of short interest (12.04% of the float). As the company’s share price gains, the short interest may have to scramble to buy shares (short squeeze) to cover those short positions. This could have the impact of driving a company’s shares to new heights.

The Traders News Group

original report below

VUZI Has Tools for the Future of Healthcare

Golden cross formation on the chart, Oversold, Low float, Tele-medicine & wearable tech are both HOT sectors

Good day everyone,

We are initiating coverage of Vuzix Corporation (NASDAQ: VUZI), a company that designs, manufactures, markets, and sells augmented reality (AR) wearable display and computing devices.

Current price $1.75 per share
Outstanding (est.) 33.1 million shares
Float (est.) 27.4 million shares
% Held by Insiders and Institutions approx. 28%
Cash on hand most recent quarter $10.61M
52-week range $.86 to $5.00

We have been watching VUZI shares for a while and feel like right now could be the time to talk about the shares given the current price. After bottoming out in mid-March, VUZI shares have gained some traction, eclipsing their 50 DMA of $1.41 and closing in on their 200 DMA of $1.95. A break past $1.95 may create a catalyst for the company shares to seek a new, higher resistance level.

Trading volumes were strong through April and the shares are leading their SMA 20, both potential indicators of trending shares.

VUZI shares are trading 65% off their 52-week high.

11.9% of the outstanding shares are held by insiders and 15.3% are held by institutions. Insiders with a vested interest in the company and institutions with professionals in tech investments.

Recent analysts target:
3/19/2020 Maxim Group Reiterated Rating Buy $3.50

Vuzix AR wearable display devices are worn like eyeglasses or attach to a head worn mount to view, record, and interact with video and digital content, such as computer data, the Internet, social media, and entertainment applications.

On May 5th, the company announced it has received a replenishment order for M400 Smart Glasses orders from Gemvision to support their efforts to meet COVID-19 remote healthcare needs in the Netherlands.

Two weeks ago, VUZI announced the commercial availability of a turnkey M400 Smart Glasses Remote Worker Connectivity Bundle powered by Sprint Curiosity™ IoT. The new connectivity bundle can offer COVID-19 tele-medicine support in rural hospitals, nursing homes and other remote medical facilities.

Remote healthcare and tele-medicine are the wave of the future. Many of us have already experienced tele-medicine during the Covid 19 pandemic as clinics and doctor’s offices remain somewhat closed.

By utilizing smart-glasses, nurses, EMTs and other front line healthcare providers could call and consult with a doctor while keeping their hands free to perform any treatment.

Wounds can be verbally described, but that is difficult. When a physician can view a wound, it helps greatly. The view of a patient seen by a medical professional wearing smart-glasses could be immediately shared with other members of the care team.

Patients with transmissible diseases, such as Covid 19, could be physically seen by fewer medical professionals, reducing the incidence of transmission, and reducing costs at the same time.

As we all begin to visualize what the world may look like after the Covid 19 pandemic, tele-medicine could play a regular role in healthcare. We believe VUZI could be at the forefront of that new paradigm and we believe the investment community may be evaluating that inevitability as the trend in VUZI shares indicates.

As part of your due diligence you should read this press release:

VUZI offers extraordinary technology, offering benefit to the way we work and live. It is within our nature to resist wearing any kind of extraneous product on our heads (think of face masks). That aversion may be going by the wayside as we realize the benefits of minimal contact in today’s world.

In March, while addressing the current health crisis, the company stated, “there has never been a better time to work hands-free and remotely with AR smart glasses than today.”

The displays (glasses) VUZI sells can be engineered for the industries they partner with. Some partners VUZI has worked with include:

US Department of Defense

The VUZI intellectual property portfolio consists of over 150 patents.

VUZIX utilizes Waveguide technology. Waveguides are thin (about 1 mm), transparent, optical elements that take a projected virtual image and relay it to the eye while expanding the exit pupil (viewing window) at the same time. Waveguides are transparent, so the smart glasses do not need to be removed to complete other tasks. This is the technology that sets VUZI apart from the competition.

In a significant development, the company recently announced that their M400 Smart Glasses are now supported by Bitnamic, a German-based software company that develops smart services for remote service, inspection, and maintenance of highly complex machines. If the technician wears Vuzix M400 Smart Glasses during the live broadcast, there is no need to look at a smartphone or tablet.

Vuzix Blade Smart-glasses – Blade is a new way to use smart glasses. Waveguide optics project a see-through image to the user. These advanced optics do not obstruct regular vision and allow the user to perfectly switch between the digital world and reality. Sold in two models.

M-Series Smart-glasses – The Vuzix M-Series boasts the new M400 and cost-effective M300XL. Both models are rich in features, including nHD color displays, voice control, touchpad navigation, three axis gyroscope integrated head-tracking, 64GB internal flash memory, and left or right eye use.

Vuzix Labs Smart Swim – Smart Swim™ is a head-up display for swimmers, providing workout status and information about their swim. This enables users to continue uninterrupted and reach optimum performance.

Vuzix Remote Assist – Vuzix Remote Assist (VRA) is a streaming video app optimized for the growing lineup of Vuzix Smart Glasses. VRA increases productivity and customer satisfaction by sharing information between field technicians and remote support experts.

VUZIX also sells a complete line of accessories, apps, and merchandise.

VUZI shares are closing in on their 200-day moving average of $1.95 per share after crossing their 50 DMA last month. A break past these moving averages can mean the shares are ready to find a new, higher resistance level. Recent gains have caused VUZI shares to lead their SMA 20 by 10.9%.

VUZI Chart –

VUZI, as a leader in smart-glasses technology, could be at the forefront of a worldwide trend. Their continuing improvement in their products may expand the markets available to them. We believe their shares may reflect that status in the near term.

The Traders News Group


Privacy Policy and Disclaimer

Your Consent

By using our site, you consent to our online privacy policy and disclaimer.

Do we disclose any information to outside parties?

We hate spam and we do not sell, trade, or otherwise transfer to outside parties your personally identifiable information.

What information do we collect?

We collect information from you when you subscribe to our newsletter or fill out a form. This includes your email address only.

When registering on our site, as appropriate, you may be asked to enter your: e-mail address

What do we use your information for?

When we collect your email it is used for one purpose to send you the free information you requested about small cap stocks. Please read our disclaimer carefully before viewing our emails.

Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, other than for the express purpose of delivering the information on small cap stocks that you requested.

We send periodic emails

The email address you provide may be used to send you information, respond to inquiries, and/or other requests or questions.

How do we protect your information?

We implement a variety of security measures to maintain the safety of your personal information when you enter, submit, your email address. We use a secure third party to send email to you.

Because we value your privacy we have taken the necessary precautions to be in compliance with the California Online Privacy Protection Act. We therefore will not distribute your personal information to outside parties without your consent.

Online Privacy Policy Only

This online privacy policy applies only to information collected through our website and not to information collected offline.

Contacting Us

If there are any questions regarding this privacy policy or disclaimer you may contact us using the information below.

Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.

Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.

PLEASE NOTE WELL: TNS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. TNS LLC’s parent company has been compensate.d fifteen thousand dollars cash via bank wir.e by venado media llc for this weeks coverage of vuzi. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.

TNS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. TNS LLC is not a Broker/Dealer and does not engage in high frequency trading.